Protein Interface Prediction Using Synergistic Peptide Pair MSA
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting protein-protein interaction structures are inefficient and resource-intensive, lacking the precision needed for effective small molecule and antibody design.
Innovation Solution
A method involving high-throughput analysis of variant peptide pairs, identification of synergistic pairs, and multiple sequence alignment (MSA) to predict protein complex structures, enhanced by machine-learning models for improved accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional structure prediction methods are used, then comprehensive analysis can be performed, but computational efficiency is low and resource consumption is high
Solution Approach 1:
The patent performs preliminary multiple sequence alignment (MSA) on libraries of variant peptides before conducting structure prediction. By pre-aligning sequences and identifying conserved residues and co-evolutionary patterns in advance, the method prepares optimized input data that accelerates subsequent structure prediction computations, thereby improving computational efficiency while maintaining accuracy.
2Reliability
If traditional structure prediction methods are used, then comprehensive analysis can be performed, but resource consumption is high
Solution Approach 1:
The patent extracts and utilizes only the most informative features from peptide sequences through MSA, specifically focusing on conserved residues, co-evolutionary signals, and alignment patterns. By extracting these key features rather than processing complete sequence data, the method reduces computational resource consumption while maintaining prediction accuracy.
Solution Approach 2:
The patent applies local quality by focusing computational attention on specific regions of the peptide sequences that are most relevant for structure prediction. Through MSA, the method identifies locally conserved regions and functionally important residues, concentrating computational resources on these critical areas rather than uniformly processing entire sequences, thereby improving efficiency without sacrificing reliability.
3Manufacturing precision
If extensive trial-and-error methods are used in small molecule and antibody design, then thorough optimization can be achieved, but time and resources are consumed
Solution Approach 1:
The patent performs preliminary structure prediction and interface analysis using MSA-based methods before initiating small molecule or antibody design. By predicting protein complex structures and identifying key interaction residues in advance, the method provides a solid structural foundation that guides subsequent design efforts, reducing the need for extensive trial-and-error optimization and accelerating development timelines while maintaining design precision.
Data Source
AI summary
The present disclosure provides a method of predicting a structure of an interface between a target peptide and a targeting peptide. The method leverages test pairs of variants of a target peptide and variants of a targeting peptide and their binding affinities measured by a high-throughput analysis. Synergistic pairs among the test pairs are selected and multiple sequence alignment (MSA) of the selected pairs is performed to predict a structure of the protein complex formed with the target peptide and the targeting peptide. Structure prediction using MSA of the synergistic pairs provides for improved results, thereby paving the path for downstream analyses, e.g., small molecule design for molecular glues or antibody design.